Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 16

Red Blood Cell Distribution Width as a Biomarker in Type 2 Diabetes Mellitus: Technical Notes [Response to Letter]

Authors Arkew M , Asmerom H , Tesfa T , Tsegaye S, Gemechu K , Bete T, Haile K 

Received 20 February 2023

Accepted for publication 21 February 2023

Published 24 February 2023 Volume 2023:16 Pages 533—534

DOI https://doi.org/10.2147/DMSO.S409344



Mesay Arkew,1 Haftu Asmerom,1 Tewodros Tesfa,1 Setegn Tsegaye,2 Kabtamu Gemechu,1 Tilahun Bete,3 Kassahun Haile4

1School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; 2College of Health and Medical Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 3Department of Psychiatry, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; 4Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wolkite University, Wolkite, Ethiopia

Correspondence: Mesay Arkew, School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, P.O. Box: 235, Harar, Ethiopia, Tel +251926678740, Email [email protected]; [email protected]


View the original paper by Mr Arkew and colleagues

This is in response to the Letter to the Editor


Dear editor

We would like to acknowledge the author for sharing this interesting letter of technical note. Saying this, we do have some comments and suggestions.

1. Quality assurance in hematology covers the preanalytical, analytical and post analytical phases; all phases should be maintained to achieve accurate and reliable test results. It is known that the majority of laboratory errors are accounted for preanalytical errors and there are methods used to prevent its occurrence like delta check. Delta checks assess any change in a stable hematological parameter including the MCV, MCHC, and RDW. RDW is one of the stable parameters that could not be affected by short term patient events and it is reported that MCV, MCHC and RDW are stable for about 24 hours in vivo.

2. In two of our published articles ie

I. Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: A comparative cross-sectional study.

II. Red Blood Cell Parameters and Their Correlation with Glycemic Control Among Type 2 Diabetic Adult Patients in Eastern Ethiopia: A Comparative Cross-Sectional Study.

For both of the above articles, we have mentioned that the blood samples were processed within 2 hours of specimen collection which is recommended by the International Council for Standardization in Haematology (ICSH). Again, in our case the potential time delay was too low since blood specimen was collected in the phlebotomy area of the laboratory and analyzed in the central laboratory. Indeed, the issue of time delay, transport and storage is not our case. So, the author needs to revise their letter regarding our paper.

The article published by Biadgo B.et al (cited as reference 6 in the letter) also mentioned the sample collection and analysis time in the quality assurance and management section of their paper. So, the letter needs amendment in this regard.

3. In addition, there is a citation problem specifically reference number 5 is miss cited. We think the correct article is entitled “Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: A comparative cross-sectional study”. This line/citation needs a revision.

Disclosure

The authors report no conflicts of interest related to this communication.

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.